Skip to content

HBV-IN-39-d3

C23H28FNO6 — CID 134210692

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC(6S)-6-tert-butyl-1-fluoro-9-(3-methoxypropoxy)-2-oxo-10-(trideuteriomethoxy)-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid
SMILES[2H]C([2H])([2H])Oc1cc2c(cc1OCCCOC)C[C@@H](C(C)(C)C)n1cc(C(=O)O)c(=O)c(F)c1-2
InChIInChI=1S/C23H28FNO6/c1-23(2,3)18-10-13-9-17(31-8-6-7-29-4)16(30-5)11-14(13)20-19(24)21(26)15(22(27)28)12-25(18)20/h9,11-12,18H,6-8,10H2,1-5H3,(H,27,28)/t18-/m0/s1/i5D3
InChIKeyZKTCGTSGMDPTNG-QEPJKHGMSA-N
MW436.49 g/mol
LogP3.92
Rot. Bonds8

About HBV-IN-39-d3

HBV-IN-39-d3 (PubChem CID 134210692) has the molecular formula C23H28FNO6 and a molecular weight of 436.49 g/mol. Its IUPAC name is (6S)-6-tert-butyl-1-fluoro-9-(3-methoxypropoxy)-2-oxo-10-(trideuteriomethoxy)-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid.

Molecular Properties

Compound NameHBV-IN-39-d3
PubChem CID134210692
Molecular FormulaC23H28FNO6
Molecular Weight436.49 g/mol
Exact Mass436.21
IUPAC Name(6S)-6-tert-butyl-1-fluoro-9-(3-methoxypropoxy)-2-oxo-10-(trideuteriomethoxy)-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid
SMILES[2H]C([2H])([2H])Oc1cc2c(cc1OCCCOC)C[C@@H](C(C)(C)C)n1cc(C(=O)O)c(=O)c(F)c1-2
InChIInChI=1S/C23H28FNO6/c1-23(2,3)18-10-13-9-17(31-8-6-7-29-4)16(30-5)11-14(13)20-19(24)21(26)15(22(27)28)12-25(18)20/h9,11-12,18H,6-8,10H2,1-5H3,(H,27,28)/t18-/m0/s1/i5D3
InChIKeyZKTCGTSGMDPTNG-QEPJKHGMSA-N
XLogP3.92
TPSA86.99 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms31
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500436.49
LogP ≤ 53.92
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze HBV-IN-39-d3 with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of HBV-IN-39-d3?
The IUPAC name of HBV-IN-39-d3 (CID 134210692) is (6S)-6-tert-butyl-1-fluoro-9-(3-methoxypropoxy)-2-oxo-10-(trideuteriomethoxy)-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid.
What is the SMILES notation for HBV-IN-39-d3?
The canonical SMILES for HBV-IN-39-d3 is [2H]C([2H])([2H])Oc1cc2c(cc1OCCCOC)C[C@@H](C(C)(C)C)n1cc(C(=O)O)c(=O)c(F)c1-2.
What is the InChIKey of HBV-IN-39-d3?
The InChIKey is ZKTCGTSGMDPTNG-QEPJKHGMSA-N. The full InChI is InChI=1S/C23H28FNO6/c1-23(2,3)18-10-13-9-17(31-8-6-7-29-4)16(30-5)11-14(13)20-19(24)21(26)15(22(27)28)12-25(18)20/h9,11-12,18H,6-8,10H2,1-5H3,(H,27,28)/t18-/m0/s1/i5D3.
What are the key properties of HBV-IN-39-d3?
HBV-IN-39-d3 has a molecular weight of 436.49 g/mol, XLogP of 3.92, 8 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for HBV-IN-39-d3 is sourced from PubChem (CID 134210692), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.